Renalytix Plc
RENXF
$0.091
-$0.039-30.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 522.00K | 586.00K | 535.00K | 709.00K | 459.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 522.00K | 586.00K | 535.00K | 709.00K | 459.00K |
| Cost of Revenue | 422.00K | 550.00K | 601.00K | 480.00K | 502.00K |
| Gross Profit | 100.00K | 36.00K | -66.00K | 229.00K | -43.00K |
| SG&A Expenses | 3.27M | 4.52M | 3.88M | 5.39M | 6.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.61M | 6.11M | 6.67M | 9.04M | 9.35M |
| Operating Income | -4.09M | -5.53M | -6.14M | -8.34M | -8.89M |
| Income Before Tax | -4.73M | -7.07M | -7.74M | -8.48M | -10.15M |
| Income Tax Expenses | 2.00K | 0.00 | -- | 4.00K | -- |
| Earnings from Continuing Operations | -4.73M | -7.07M | -7.74M | -8.49M | -10.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.73M | -7.07M | -7.74M | -8.49M | -10.15M |
| EBIT | -4.09M | -5.53M | -6.14M | -8.34M | -8.89M |
| EBITDA | -4.03M | -5.46M | -6.07M | -8.23M | -8.76M |
| EPS Basic | -0.04 | -0.05 | -0.08 | -0.09 | -0.11 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.04 | -0.05 | -0.06 |
| EPS Diluted | -0.04 | -0.05 | -0.08 | -0.09 | -0.11 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.04 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 105.70M | 138.16M | 97.66M | 97.27M | 94.77M |
| Average Diluted Shares Outstanding | 105.70M | 138.16M | 97.66M | 97.27M | 94.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
